Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Oncology Reports|January 24, 2012
Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patientsRyu Shimada, Hisae Iinuma, Takuya Akahane, et al.
Oncology Letters|September 12, 2012
Association of plasma VEGF-A, soluble VEGFR-1 and VEGFR-2 levels and clinical response and survival in advanced colorectal cancer patients receiving bevacizumab with modified FOLFOX6Yoshiko Aoyagi, Hisae Iinuma, Atsushi Horiuchi, et al.
Oncology Letters|April 30, 2017
Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancerHitoshi Dejima, Hisae Iinuma, Rie Kanaoka, et al.
Oncology Reports|January 24, 2012
Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patientsAtsushi Horiuchi, Hisae Iinuma, Takuya Akahane, et al.
Oncology Reports|February 19, 2011
Clinical significance of intraperitoneal CD44 mRNA levels of magnetically separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patientsMasahiro Horikawa, Hisae Iinuma, Taisuke Inoue, et al.
Oncology|March 18, 2011
Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancerHajime Shibuya, Hisae Iinuma, Ryu Shimada, et al.
Oncology|July 10, 2010
Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgeryKeisuke Nakamura, Hisae Iinuma, Yoshiko Aoyagi, et al.
Oncology|April 5, 2017
Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal CancerMitsuo Tsukamoto, Hisae Iinuma, Takahiro Yagi, et al.
Oncology Reports|March 13, 2012
Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancerTaisuke Inoue, Hisae Iinuma, Etsushi Ogawa, et al.
Oncology Reports|November 26, 2014
Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancerYoshihisa Fukushima, Hisae Iinuma, Mitsuo Tsukamoto, et al.
Pageof 8